Matches in Wikidata for { <http://www.wikidata.org/entity/Q102154951> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q102154951 description "clinical trial" @default.
- Q102154951 description "ensayo clínico" @default.
- Q102154951 description "ensayu clínicu" @default.
- Q102154951 description "klinisch onderzoek" @default.
- Q102154951 description "клінічне випробування" @default.
- Q102154951 description "临床试验" @default.
- Q102154951 name "Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain" @default.
- Q102154951 name "Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain" @default.
- Q102154951 type Item @default.
- Q102154951 label "Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain" @default.
- Q102154951 label "Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain" @default.
- Q102154951 prefLabel "Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain" @default.
- Q102154951 prefLabel "Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain" @default.
- Q102154951 P1050 Q102154951-DED7AA13-4450-48B2-B2E7-BF499992EE22 @default.
- Q102154951 P1132 Q102154951-68554F84-0888-4AFD-A041-10FB3264532C @default.
- Q102154951 P1476 Q102154951-9D268A41-C7EA-437A-BE0F-C1F1C5BFCC07 @default.
- Q102154951 P17 Q102154951-75A87E88-9EBC-4366-909E-F3F4F1704472 @default.
- Q102154951 P1813 Q102154951-2ABAB09B-811E-4416-9791-B6556B76ACE0 @default.
- Q102154951 P2899 Q102154951-F7BBB4E3-85E8-466F-867C-F135AA211D1B @default.
- Q102154951 P3098 Q102154951-4196ACFE-206F-43E8-BFEC-C364050ACE70 @default.
- Q102154951 P31 Q102154951-A2A13F17-01E4-4F79-8309-3A7E2E7E22A1 @default.
- Q102154951 P580 Q102154951-5E70F397-2F0B-4F3B-88AB-F546A2170D4C @default.
- Q102154951 P582 Q102154951-5E2CF4EF-17F1-4570-9B6E-5778F82A018B @default.
- Q102154951 P8005 Q102154951-7E299182-B4E0-4AE6-B962-3F39CD4EE4ED @default.
- Q102154951 P8363 Q102154951-124A1831-3655-44E2-848D-4831BC5A0929 @default.
- Q102154951 P1050 Q205764 @default.
- Q102154951 P1132 "+80" @default.
- Q102154951 P1476 "Effectiveness and Safety of Elagolix Treatment in Moderate to Severe Endometriosis-associated Pain in Routine Clinical Practice in Israel- ENDORSE Study" @default.
- Q102154951 P17 Q801 @default.
- Q102154951 P1813 "ENDORSE" @default.
- Q102154951 P2899 "+18" @default.
- Q102154951 P3098 "NCT04630990" @default.
- Q102154951 P31 Q30612 @default.
- Q102154951 P580 "2020-11-15T00:00:00Z" @default.
- Q102154951 P582 "2023-11-01T00:00:00Z" @default.
- Q102154951 P8005 Q76649614 @default.
- Q102154951 P8363 Q818574 @default.